文献速递临床试验与 GCP真实世界研究与卫生经济

鞋内硬性支撑插片治疗第一跖趾关节骨关节炎(SIMPLE试验):随机对照试验研究方案

Shoe-stiffening inserts for first metatarsophalangeal joint osteoarthritis (the SIMPLE trial): study protocol for a randomised controlled trial.
PubMed 文献 · Trials · 2017-04-27

本文描述了一项平行组、参与者和评估者盲法的随机对照试验设计,比较全长鞋内硬性支撑插片加康复治疗与假鞋垫加康复治疗对第一跖趾关节骨关节炎疼痛的效果。计划纳入90例受试者,主要结局为足部健康状态问卷的足部疼痛维度,主要终点为12周,并在基线及4、12、24、52周评估。研究还将进行经济学分析和生物力学分析。

要点

  • SIMPLE试验比较鞋内硬性支撑插片与假鞋垫对第一跖趾关节骨关节炎疼痛的效果。
  • 计划纳入90例受试者,主要终点为12周,主要结局为足部健康状态问卷足部疼痛维度。
  • 将在1周时用三维运动分析系统评估干预的运动学效应,并进行成本效果和成本效用分析。

核心结论

  • 该研究将确定鞋内硬性支撑插片是否为缓解第一跖趾关节骨关节炎相关疼痛的成本效果良好的干预措施。
  • 生物力学分析将为了解鞋内硬性支撑插片的作用机制提供有用信息。

研究设计与样本

  • 平行组、参与者和评估者盲法的随机对照试验。
  • 计划纳入90例第一跖趾关节骨关节炎受试者,随机接受全长鞋内硬性支撑插片(Carbon Fibre Spring Plate,Paris Orthotics,Vancouver,BC,Canada)加康复治疗或假鞋垫加康复治疗。
  • 结局在基线、4、12、24和52周获取,主要终点为12周。
  • 按意向性治疗原则分析,并进行成本效果和成本效用分析。
  • 在1周时使用三维运动分析系统和多节段足部模型检查干预的运动学效应。

关键数值与推荐

  • 主要结局为足部健康状态问卷(FHSQ)的足部疼痛维度。
  • 次要结局包括FHSQ功能维度、第一跖趾关节疼痛严重程度(100 mm视觉模拟量表)、症状总体变化(15点Likert量表)、健康状况(Short-Form-12® Version 2.0和EuroQol(EQ-5D-5L™)问卷)、急救药物和协同干预使用、自我报告的不良事件和身体活动水平(Incidental and Planned Activity Questionnaire)。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: This article describes the design of a parallel-group, participant- and assessor-blinded randomised controlled trial comparing the effectiveness of shoe-stiffening inserts versus sham shoe insert(s) for reducing pain associated with first metatarsophalangeal joint (MTPJ) osteoarthritis (OA). METHODS: Ninety participants with first MTPJ OA will be randomised to receive full-length shoe-stiffening insert(s) (Carbon Fibre Spring Plate, Paris Orthotics, Vancouver, BC, Canada) plus rehabilitation therapy or sham shoe insert(s) plus rehabilitation therapy. Outcome measures will be obtained at baseline, 4, 12, 24 and 52 weeks; the primary endpoint for assessing effectiveness being 12 weeks. The primary outcome measure will be the foot pain domain of the Foot Health Status Questionnaire (FHSQ). Secondary outcome measures will include the function domain of the FHSQ, severity of first MTPJ pain (using a 100-mm Visual Analogue Scale), global change in symptoms (using a 15-point Likert scale), health status (using the Short-Form-12® Version 2.0 and EuroQol (EQ-5D-5L™) questionnaires), use of rescue medication and co-interventions, self-reported adverse events and physical activity levels (using the Incidental and Planned Activity Questionnaire). Data will be analysed using the intention-to-treat principle. Economic analysis (cost-effectiveness and cost-utility) will also be performed. In addition, the kinematic effects of the interventions will be examined at 1 week using a three-dimensional motion analysis system and multisegment foot model. DISCUSSION: This study will determine whether shoe-stiffening inserts are a cost-effective intervention for relieving pain associated with first MTPJ OA. The biomechanical analysis will provide useful insights into the mechanism of action of the shoe-stiffening inserts. TRIAL REGISTRATION: Australian New Zealand Clinical Trials Registry, identifier: ACTRN12616000552482 . Registered on 28 April 2016.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Munteanu SE, Landorf KB, McClelland JA, et al. Shoe-stiffening inserts for first metatarsophalangeal joint osteoarthritis (the SIMPLE trial): study protocol for a randomised controlled trial. Trials. 2017. PMID: 28449699. doi:10.1186/s13063-017-1936-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。